Walter & Keenan Financial Consulting Co. MI ADV Buys 100 Shares of Illumina, Inc. (ILMN)

Walter & Keenan Financial Consulting Co. MI ADV increased its position in Illumina, Inc. (NASDAQ:ILMN) by 1.5% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 6,650 shares of the life sciences company’s stock after buying an additional 100 shares during the period. Walter & Keenan Financial Consulting Co. MI ADV’s holdings in Illumina were worth $1,154,000 as of its most recent filing with the SEC.

Several other hedge funds also recently modified their holdings of ILMN. First Citizens Bank & Trust Co. increased its stake in shares of Illumina by 0.4% in the second quarter. First Citizens Bank & Trust Co. now owns 3,088 shares of the life sciences company’s stock worth $536,000 after buying an additional 12 shares during the period. Patten Group Inc. increased its position in Illumina by 2.7% in the first quarter. Patten Group Inc. now owns 965 shares of the life sciences company’s stock valued at $166,000 after buying an additional 25 shares in the last quarter. Puzo Michael J increased its position in Illumina by 0.4% in the second quarter. Puzo Michael J now owns 5,955 shares of the life sciences company’s stock valued at $1,032,000 after buying an additional 25 shares in the last quarter. Gemmer Asset Management LLC increased its position in Illumina by 5.7% in the first quarter. Gemmer Asset Management LLC now owns 686 shares of the life sciences company’s stock valued at $117,000 after buying an additional 37 shares in the last quarter. Finally, Eqis Capital Management Inc. increased its position in Illumina by 0.6% in the second quarter. Eqis Capital Management Inc. now owns 6,914 shares of the life sciences company’s stock valued at $1,200,000 after buying an additional 38 shares in the last quarter. 93.81% of the stock is owned by institutional investors and hedge funds.

Illumina, Inc. (NASDAQ:ILMN) opened at 199.23 on Thursday. The firm’s 50-day moving average price is $178.82 and its 200 day moving average price is $173.34. Illumina, Inc. has a 52-week low of $119.37 and a 52-week high of $199.95. The firm has a market cap of $29.09 billion, a price-to-earnings ratio of 39.97 and a beta of 0.83.

Illumina (NASDAQ:ILMN) last announced its quarterly earnings results on Tuesday, August 1st. The life sciences company reported $0.82 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.68 by $0.14. The business had revenue of $662 million for the quarter, compared to the consensus estimate of $642.38 million. Illumina had a return on equity of 19.69% and a net margin of 30.27%. The business’s revenue was up 10.3% on a year-over-year basis. During the same quarter last year, the business posted $0.86 EPS. On average, equities research analysts forecast that Illumina, Inc. will post $3.65 EPS for the current year.

WARNING: This piece was first published by Ticker Report and is owned by of Ticker Report. If you are accessing this piece on another domain, it was illegally stolen and republished in violation of United States and international copyright & trademark laws. The original version of this piece can be viewed at https://www.tickerreport.com/banking-finance/2796879/walter-keenan-financial-consulting-co-mi-adv-buys-100-shares-of-illumina-inc-ilmn.html.

Several equities analysts have weighed in on the company. Barclays PLC reaffirmed an “equal weight” rating and issued a $150.00 target price on shares of Illumina in a research report on Wednesday. Vetr raised Illumina from a “hold” rating to a “buy” rating and set a $209.78 target price for the company in a research report on Wednesday. Canaccord Genuity raised Illumina from a “hold” rating to a “buy” rating and lifted their target price for the company from $170.00 to $215.00 in a research report on Monday. BidaskClub raised Illumina from a “sell” rating to a “hold” rating in a research report on Monday. Finally, Zacks Investment Research downgraded Illumina from a “buy” rating to a “hold” rating in a research report on Friday, August 4th. Two equities research analysts have rated the stock with a sell rating, ten have given a hold rating and eleven have given a buy rating to the company. Illumina has an average rating of “Hold” and an average target price of $177.01.

In other news, Director Jay T. Flatley sold 15,000 shares of Illumina stock in a transaction on Tuesday, July 18th. The stock was sold at an average price of $170.77, for a total transaction of $2,561,550.00. Following the transaction, the director now directly owns 534,176 shares in the company, valued at approximately $91,221,235.52. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, EVP Omead Ostadan sold 1,671 shares of Illumina stock in a transaction on Monday, August 7th. The shares were sold at an average price of $195.26, for a total value of $326,279.46. Following the transaction, the executive vice president now owns 24,571 shares in the company, valued at $4,797,733.46. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 134,010 shares of company stock worth $23,946,015. 1.60% of the stock is owned by insiders.

About Illumina

Illumina, Inc (Illumina) is a provider of sequencing- and array-based solutions for genetic analysis. The Company operates through two segments: Core Illumina and the consolidated variable interest entities (VIEs), which include the activities of GRAIL, Inc (GRAIL) and Helix Holdings I, LLC (Helix). Core Illumina consists of its core operations.

Want to see what other hedge funds are holding ILMN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Illumina, Inc. (NASDAQ:ILMN).

Institutional Ownership by Quarter for Illumina (NASDAQ:ILMN)

Receive News & Ratings for Illumina Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Illumina Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

How to Trade on Forex – 8 Steps for Beginners
How to Trade on Forex – 8 Steps for Beginners
Super Nintendo World Theme Park Officially Starts Construction
Super Nintendo World Theme Park Officially Starts Construction
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Camera Zooms In and Can Recognize Faces
Camera Zooms In and Can Recognize Faces
Netflix Could See 150 Million Worldwide Subscribers
Netflix Could See 150 Million Worldwide Subscribers
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back


Leave a Reply

© 2006-2017 Ticker Report. Google+.